VIT 3.95% 7.3¢ vitura health limited

quaterly no foreseeable sales, page-6

  1. 709 Posts.
    hard man - as I have said before, I always expected Colltech to be a great cash cow and it could still be if it racks up some significant sales. It's been over 18 months since Ovicol C received its final approvals and we have not seen any major sales contracts materialize and for a one product company, thats appalling. Either the board and management have no idea of the market they are in or there is a major oversupply of cheap alternative collagen!!!!!

    As for selling my shares, I have been here since IPO and have continued to buy along the way so I will sink with the ship and continue to vent my frustration on the poor performance of the Colltech board and management. I remind they on a mothly basis by email as to their inability to achieve any significant sales.



 
watchlist Created with Sketch. Add VIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.